Biohermes is a member on the "Export Allow List" issued by the Chinese Ministry of Commerce (MOFCOM) for anti-epidemic products, including SARS-CoV-2 Neutralizing Antibodies Test Kit (enzyme linked immunosorbent assay), SARS-CoV-2 IgG/IgM Antibody Test (Lateral Flow Assay) and SARS-CoV-2 Antigen Test Kit (Lateral Flow Assay). The principle of antigen test is to check whether pathogens exist in the human body through stool and sputum samples, while antibody test focuses on checking if antibodies have been produced against pathogens through blood samples. The two methods are complementary to each other. Biohermes is one of the few Chinese manufacturers that can export both antibody test kits and antigen test kits, providing customized and professional solutions for various needs.

Biohermes SARS-CoV-2 Antigen Test Kit (Lateral Flow Assay) received the approval of Germany BfArM, and is under PEI clinical validation. It is on the list of Austrian Federal Office for Safety in Health Care and the Belgian Competent Authority for medical devices and EU Common List, which can help more countries use our products in confidence fight against "COVID-19 epidemic" globally and the successful acquisition of these certificates marks that Biohermes has taken a further step in fighting COVID-19 epidemic. As an important member of IVD industry, Biohermes will still take actions to implement the corporate missions. The epidemic will be ended, and we will finally win the battle against COVID-19.